Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander J Heiler

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
ACS Applied Materials & Interfaces|July 7, 2025
Engineering Lymphatic Transport of Nanoparticles through Emulsion PolymerizationAlexander J Heiler, Tae Hee Yoon, Maya Levitan, et al.
Biomaterials Science|September 25, 2024
Different leukocyte subsets are targeted by systemic and locoregional administration despite conserved nanomaterial characteristics optimal for lymph node deliveryPaul A Archer, Alexander J Heiler, Alisyn R Bourque, et al.
Biomacromolecules|June 3, 2026
Orthogonal Chemistry Enables Precision Nanoparticle Cofunctionalization for Tuning Immune Stimulation and Antigen PresentationAlexander J Heiler, Claire A McClain, Samuel N Lucas, et al.
Biomaterials|October 22, 2021
Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targetingDavid M Francis, Margaret P Manspeaker, Paul A Archer, et al.
Mabs|October 15, 2024
CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibodyCristina Melero, S Jimmy Budiardjo, Anahita Daruwalla, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
ACS Applied Materials & Interfaces|July 7, 2025
Engineering Lymphatic Transport of Nanoparticles through Emulsion PolymerizationAlexander J Heiler, Tae Hee Yoon, Maya Levitan, et al.
Biomaterials Science|September 25, 2024
Different leukocyte subsets are targeted by systemic and locoregional administration despite conserved nanomaterial characteristics optimal for lymph node deliveryPaul A Archer, Alexander J Heiler, Alisyn R Bourque, et al.
Biomacromolecules|June 3, 2026
Orthogonal Chemistry Enables Precision Nanoparticle Cofunctionalization for Tuning Immune Stimulation and Antigen PresentationAlexander J Heiler, Claire A McClain, Samuel N Lucas, et al.
Biomaterials|October 22, 2021
Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targetingDavid M Francis, Margaret P Manspeaker, Paul A Archer, et al.
Mabs|October 15, 2024
CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibodyCristina Melero, S Jimmy Budiardjo, Anahita Daruwalla, et al.
Pageof 1